Malaria Vaccine 'could be widespread by 2015'

No Image

The world's first malaria vaccine could be in widespread use within two years following "significant" results from an ongoing clinical trial.

Researchers reported at a malaria conference in Durban, South Africa, that the jab continues to protect a substantial proportion of babies and young children 18 months after vaccination. The mosquito-borne disease kills around 660,000 people every year, most of them children in Sub-Saharan Africa.

British pharmaceutical firm GlaxoSmithKline (GSK), which makes the vaccine, said it would apply for a licence from the European Medicines Agency next year.

Editor's Comment
Consult, get buy-ins first for 6 to 6 policy, Hon Minister

While the minister is of the view that the proposal would have significant positive economic impact, the entertainment industry players believe otherwise. The issue has over the weeks become a hot potato. But what is of essence right now is that the country needs liberal ideas to move in the right direction While opening up the economy may sound quite interesting to the ear, rolling out extended trading hours through pilot programmes without...

Have a Story? Send Us a tip
arrow up